Year |
Citation |
Score |
2024 |
Rarick KR, Li K, Teng RJ, Jing X, Martin DP, Xu H, Jones DW, Hogg N, Hillery CA, Garcia G, Day BW, Naylor S, Pritchard KA. Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease. Free Radical Biology & Medicine. PMID 38336101 DOI: 10.1016/j.freeradbiomed.2024.01.052 |
0.597 |
|
2021 |
Neu SD, Strzepa A, Martin D, Sorci-Thomas MG, Pritchard KA, Dittel BN. Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice. Antioxidants (Basel, Switzerland). 10. PMID 34572970 DOI: 10.3390/antiox10091338 |
0.529 |
|
2021 |
Teng RJ, Jing X, Martin DP, Hogg N, Haefke A, Konduri GG, Day BW, Naylor S, Pritchard KA. N-Acetyl-Lysyltyrosylcysteine Amide, a Novel Systems Pharmacology Agent, Reduces Bronchopulmonary Dysplasia in Hyperoxic Neonatal Rat Pups. Free Radical Biology & Medicine. PMID 33607217 DOI: 10.1016/j.freeradbiomed.2021.02.006 |
0.572 |
|
2020 |
Weihrauch D, Martin DP, Jones D, Krolikowski J, Struve J, Naylor S, Pritchard KA. Inhibition of myeloperoxidase increases revascularization and improves blood flow in a diabetic mouse model of hindlimb ischaemia. Diabetes & Vascular Disease Research. 17: 1479164120907971. PMID 32223319 DOI: 10.1177/1479164120907971 |
0.54 |
|
2018 |
Martin D, Yu G, Liang Y, Hillery C, Naylor S, Pritchard K. Neutrophils in sickle cell disease: the missing candidate – myeloperoxidase Free Radical Biology and Medicine. 128. DOI: 10.1016/J.Freeradbiomed.2018.10.037 |
0.432 |
|
2018 |
Teng R, Jing X, Konduri G, Martin D, Naylor S, Pritchard K. The role of myeloperoxidase in hyperoxia-induced bronchopulmonary dysplasia Free Radical Biology and Medicine. 128. DOI: 10.1016/J.Freeradbiomed.2018.10.036 |
0.415 |
|
2015 |
Jin H, Harischandra DS, Choi C, Martin D, Anantharam V, Kanthasamy A, Kanthasamy AG. Manganese and prion disease Issues in Toxicology. 2015: 574-603. |
0.555 |
|
2014 |
Harischandra DS, Kondru N, Martin DP, Kanthasamy A, Jin H, Anantharam V, Kanthasamy AG. Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease. Prion. 8: 143-53. PMID 24576946 DOI: 10.4161/Pri.28369 |
0.657 |
|
2011 |
Martin DP, Anantharam V, Jin H, Witte T, Houk R, Kanthasamy A, Kanthasamy AG. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology. 32: 554-62. PMID 21871919 DOI: 10.1016/J.Neuro.2011.07.008 |
0.591 |
|
2010 |
Choi CJ, Anantharam V, Martin DP, Nicholson EM, Richt JA, Kanthasamy A, Kanthasamy AG. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease. Toxicological Sciences : An Official Journal of the Society of Toxicology. 115: 535-46. PMID 20176619 DOI: 10.1093/Toxsci/Kfq049 |
0.64 |
|
2008 |
Anantharam V, Kanthasamy A, Choi CJ, Martin DP, Latchoumycandane C, Richt JA, Kanthasamy AG. Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling. Free Radical Biology & Medicine. 45: 1530-41. PMID 18835352 DOI: 10.1016/J.Freeradbiomed.2008.08.028 |
0.633 |
|
Show low-probability matches. |